Sanofi-Aventis to buy Chattem for $1.9 bn
French drug maker Sanofi-Aventis SA to buy US health care company Chattem Inc for about $1.9 billion in cash.
Sanofi-Aventis, based in Paris, says it will offer $93.50 per share to acquire 100 percent of Chattem, maker of consumer health care products such as Gold Bond skin care creams and Icy Hot pain relief medicine.
In a statement Monday, Sanofi-Aventis said it will launch its public tender offer for Chattem in January. It expects to complete the acquisition in the first quarter of 2010.
Chattem is based in Chattanooga, Tenn.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.